GC Pien, KB Nguyen, L Malmgaard, AR Satoskar, CA Biron. (2002) " A unique mechanism for innate cytokine promotion of T cell responses to viral infections. " J Immunol 169. 5827-37 PMID: 12421964 | Abstract and Keywords
MK Slifka, JN Blattman, DJ Sourdive, F Liu, DL Huffman, T Wolfe, A Hughes, MB Oldstone, R Ahmed, MG Von Herrath. (2003) " Preferential escape of subdominant CD8+ T cells during negative selection results in an altered antiviral T cell hierarchy. " J Immunol 170. 1231-9 PMID: 12538681 | Abstract and Keywords
VP Badovinac, SE Hamilton, JT Harty. (2003) " Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. " Immunity 18. 463-74 PMID: 12705850 | Abstract and Keywords
R Chavan, KA Marfatia, IC An, DA Garber, MB Feinberg. (2006) " Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses. " J Virol 80. 7676-87 PMID: 16840346 DOI: 10.1128/JVI.02748-05 | Abstract and Keywords
KM Khanna, CC Aguila, JM Redman, JE Suarez-Ramirez, L Lefrançois, LS Cauley. (2008) " In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection. " Eur J Immunol 38. 3304-15 PMID: 19009527 DOI: 10.1002/eji.200838602 | Abstract and Keywords
D Zhou, TL Wu, MO Lasaro, BP Latimer, EM Parzych, A Bian, Y Li, H Li, J Erikson, Z Xiang, HC Ertl. (2010) " A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge. " Mol Ther 18. 2182-9 PMID: 20877342 DOI: 10.1038/mt.2010.202 | Abstract and Keywords
TJ Moraes, GH Lin, T Wen, TH Watts. (2011) " Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease. " Vaccine 29. 6301-12 PMID: 21704101 DOI: 10.1016/j.vaccine.2011.06.022 | Abstract and Keywords